Acadia is committed to turning scientific promise into meaningful innovation that makes the difference for underserved neurological and rare disease communities around the world. Our commercial portfolio includes the first and only FDA-approved treatments for Parkinson’s disease psychosis and Rett syndrome. We are developing the next wave of therapeutic advancements with a robust and diverse pipeline that includes mid- to late-stage programs in Alzheimer’s disease psychosis and Lewy body dementia psychosis, along with earlier-stage programs that address other underserved patient needs. At Acadia, we’re here to be their difference. Please note that this position is based in Princeton, NJ or San Diego, CA. Acadia's hybrid model requires this role to work in our office three days per week on average. The Senior Director, Chemical Development will lead and advance end‑to-end drug substance development from early programs through commercial manufacturing. This role owns API process strategy, development, scale‑up, and supply, while leading high‑performing teams and overseeing external manufacturing partners. The Senior Director will define long‑term drug substance strategy, support CMC development and commercial manufacturing, and author key regulatory submissions to ensure a reliable, compliant global supply.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Director
Education Level
Ph.D. or professional degree